4078.T JPX
Sakai Chemical Industry Co., Ltd.
1W: -0.3%
1M: -8.1%
3M: -21.7%
YTD: +0.8%
1Y: +30.6%
3Y: +105.7%
5Y: +132.2%
¥3,780.00 ($23.97)
+145.00 (+3.99%)
Weekly Expected Move ±4.8%
¥3283
¥3459
¥3635
¥3811
¥3987
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$123.3B
-1.7% ▼
5Y CAGR: +0.3%
Total Liabilities
$43.9B
-12.1% ▼
5Y CAGR: +1.8%
Shareholders Equity
$78.3B
+5.2% ▲
5Y CAGR: -0.0%
Cash & Investments
$16.2B
-2.5% ▼
5Y CAGR: +12.2%
Total Debt
$21.9B
-18.9% ▼
5Y CAGR: +3.8%
Net Debt
$5.7B
-45.1% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $11.1B | $10.8B | $12.4B | $16.6B | $16.2B |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $11.1B | $10.8B | $12.4B | $16.6B | $16.2B |
| Net Receivables | $27.1B | $29.9B | $27.5B | $29.5B | $27.0B |
| Inventory | $20.8B | $23.1B | $30.1B | $28.7B | $27.0B |
| Other Current Assets | $1.2B | $1.7B | $2.0B | $1.2B | $1.3B |
| Total Current Assets | $60.3B | $65.5B | $72.1B | $76.0B | $71.4B |
| Property, Plant & Equip. | $48.6B | $48.1B | $46.8B | $40.5B | $44.5B |
| Goodwill & Intangibles | $1.7B | $1.5B | $1.4B | $1.2B | $1.1B |
| Long-Term Investments | $9.4B | $4.9B | $4.8B | $6.2B | $5.1B |
| Other Non-Current Assets | $566M | $556M | $649M | $680M | $565M |
| Total Non-Current Assets | $62.7B | $58.4B | $55.9B | $49.4B | $51.9B |
| Total Assets | $123.0B | $123.9B | $128.0B | $125.4B | $123.3B |
| — Liabilities — | |||||
| Accounts Payable | $8.0B | $9.5B | $8.6B | $9.1B | $8.6B |
| Short-Term Debt | $8.7B | $8.2B | $13.2B | $15.1B | $11.5B |
| Deferred Revenue | $2.2B | $3.3B | $2.2B | $576M | $0 |
| Other Current Liabilities | $5.3B | $2.7B | $3.2B | $5.1B | $5.7B |
| Total Current Liabilities | $26.2B | $26.8B | $29.2B | $31.8B | $27.9B |
| Long-Term Debt | $11.8B | $8.8B | $8.5B | $11.9B | $10.4B |
| Other Non-Current Liab. | $5.6B | $5.6B | $5.5B | $5.2B | $5.0B |
| Total Non-Current Liabilities | $17.6B | $14.4B | $14.1B | $18.2B | $16.0B |
| Total Liabilities | $43.7B | $41.2B | $43.3B | $50.0B | $43.9B |
| — Equity — | |||||
| Common Stock | $21.8B | $21.8B | $21.8B | $21.8B | $21.8B |
| Retained Earnings | $35.4B | $41.4B | $42.5B | $34.3B | $37.8B |
| Accumulated OCI | $2.6B | $1.1B | $1.6B | $3.2B | $3.6B |
| Total Stockholders Equity | $75.8B | $78.9B | $80.5B | $74.4B | $78.3B |
| Total Liabilities & Equity | $123.0B | $123.9B | $128.0B | $125.4B | $123.3B |
| — Key Metrics — | |||||
| Total Debt | $20.4B | $17.0B | $21.6B | $27.0B | $21.9B |
| Net Debt | $9.3B | $6.2B | $9.2B | $10.4B | $5.7B |
| Total Investments | $9.4B | $4.9B | $4.8B | $6.2B | $5.1B |